Encapsulated system of azelaic acid (4–6%) and palmitoyl tripeptide-36 in biodegradable PCL microspheres. Provides controlled release, improved tolerance, and boosted stability. Targets acne, uneven tone, redness, and post-blemish marks while supporting smoother texture and antioxidant defense. Water-dispersible, recommended at 3–5% in gels, serums, and light creams.
Encapsulated delivery system combining tranexamic acid (1–3%) with palmitoyl tripeptide-36 in biodegradable polycaprolactone (PCL) microspheres. This system improves stability, tolerance, and skin penetration, providing long-lasting controlled release. Targets hyperpigmentation, post-inflammatory
Encapsulation of azelaic acid (4–6%) in biodegradable polycaprolactone (PCL) microspheres. Provides controlled release, greater stability, and improved skin tolerance. Targets acne, rosacea, hyperpigmentation, and redness while refining texture and brightening
Innovative encapsulated actives for skin tone correction and radianceThis encapsulated active targets uneven skin tone, reducing the appearance of dark spots and promoting a more even, radiant complexion. Encapsulation ensures